METHYLPHENIDATE ER 30 MG CAP

methylphenidate hydrochloride
$2.8775per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00591387319

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

2/19/2025

Approval Type

Generic (ANDA)

FDA Application

ANDA208861

On Market Since

9/30/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-48.0%

5Y

N/A

All

-42.1%